---
figid: PMC9357648__CAS-113-2681-g003
pmcid: PMC9357648
image_filename: CAS-113-2681-g003.jpg
figure_link: /pmc/articles/PMC9357648/figure/cas15387-fig-0008/
number: FIGURE 8
figure_title: ''
caption: lncRNA XLOC013218 (XLOC) confers temozolomide (TMZ) resistance of glioma
  by promoting cell proliferation and inhibiting cell apoptosis via activation of
  the PIK3R2‐mediated PI3K/AKT signaling pathway in an Sp1‐dependent manner
article_title: lncRNA XLOC013218 promotes cell proliferation and TMZ resistance by
  targeting the PIK3R2‐mediated PI3K/AKT pathway in glioma.
citation: Jian Zhou, et al. Cancer Sci. 2022 Aug;113(8):2681-2692.
year: '2022'

doi: 10.1111/cas.15387
journal_title: Cancer Science
journal_nlm_ta: Cancer Sci
publisher_name: John Wiley and Sons Inc.

keywords:
- chemoresistance
- glioma
- lncRNA XLOC
- Sp1
- temozolomide

---
